tabun

acetylcholinesterase (Cartwright blood group) ; Homo sapiens







24 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35526478 Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents. 2022 Aug 5 1
2 33538594 Structural and Biochemical Insights into the Inhibition of Human Acetylcholinesterase by G-Series Nerve Agents and Subsequent Reactivation by HI-6. 2021 Mar 15 2
3 32454005 Synthesis and in vitro evaluation of novel non-oximes for the reactivation of nerve agent inhibited human acetylcholinesterase. 2020 Aug 1 1
4 30458057 Reversal of Tabun Toxicity Enabled by a Triazole-Annulated Oxime Library-Reactivators of Acetylcholinesterase. 2019 Mar 15 2
5 30978400 Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase. 2019 Jun 1 2
6 28446076 Behavior of uncharged oximes compared to HI6 and 2-PAM in the human AChE-tabun conjugate: a molecular modeling approach. 2018 May 2
7 29772260 Oxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations. 2018 Aug 1 1
8 30205495 Novel Group of AChE Reactivators-Synthesis, In Vitro Reactivation and Molecular Docking Study. 2018 Sep 7 1
9 26368669 Application of a dynamic in vitro model with real-time determination of acetylcholinesterase activity for the investigation of tabun analogues and oximes. 2015 Dec 25 2
10 23527625 Reactivation steps by 2-PAM of tabun-inhibited human acetylcholinesterase: reducing the computational cost in hybrid QM/MM methods. 2014 1
11 24443939 Exploring the physicochemical properties of oxime-reactivation therapeutics for cyclosarin, sarin, tabun, and VX inactivated acetylcholinesterase. 2014 Jan 21 1
12 22975155 Mechanism of interaction of novel uncharged, centrally active reactivators with OP-hAChE conjugates. 2013 Mar 25 1
13 23376121 Catalytic-site conformational equilibrium in nerve-agent adducts of acetylcholinesterase: possible implications for the HI-6 antidote substrate specificity. 2013 May 1 2
14 22343626 Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases. 2012 Apr 6 1
15 22808117 Energetics of Ortho-7 (oxime drug) translocation through the active-site gorge of tabun conjugated acetylcholinesterase. 2012 1
16 23148598 Phenyltetrahydroisoquinoline-pyridinaldoxime conjugates as efficient uncharged reactivators for the dephosphylation of inhibited human acetylcholinesterase. 2012 Dec 13 1
17 20408548 Structural evidence that human acetylcholinesterase inhibited by tabun ages through O-dealkylation. 2010 May 27 1
18 18501341 Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning. 2008 Sep 25 1
19 17370251 Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro. 2007 Nov-Dec 1
20 17562604 Structure-activity approach in the reactivation of tabun-phosphorylated human acetylcholinesterase with bispyridinium para-aldoximes. 2007 Jun 1
21 17924614 Design of a potent reactivator of tabun-inhibited acetylcholinesterase--synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203). 2007 Nov 1 1
22 17194020 New group of xylene linker-containing acetylcholinesterase reactivators as antidotes against the nerve agent cyclosarin. 2006 Oct 2
23 15379785 Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. 2004 Aug 1
24 5576158 Diisopropylphosphorofluoridate and Tabun: enzymatic hydrolysis and nerve function. 1971 Jun 18 1